
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
Table of Contents
over 22 years ago
DTC: European Styleover 22 years ago
The Ins and Outs of EAPsover 22 years ago
Is Everyone a Target?over 22 years ago
The Push for Modern Manufacturing





